← Evidence map

ArticleMolecular cancer therapeutics2015

Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25349305